Oncology Times

Lymphoma & Leukemia Resource Center

Featured Content

This collection of content will continually bring you the latest news, research and FDA approvals relating to leukemia and lymphoma.

 

New! CLL Clinical Trials

Paolo Strati, MD, a recipient of ASCO’s Young Investigator Award, describes two CLL clinical trials under way.

 

New! EU Approval of Venetoclax Plus Rituximab for the Treatment of CLL

The European Commission has approved the type-II variation application for venetoclax in combination with rituximab for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL) who have received at least one prior therapy.

Read More

CLL Milestones

Paolo Strati, MD, from The University of Texas MD Anderson Cancer Center, shares what he predicts will be the next big achievements or milestones in CLL.

 

New! Promising Results of 177Lu-Satetraxetan-Lilotomab in R/R Indolent non-Hodgkin Lymphoma

Updated results from the LYMRIT 37-01 phase I/II clinical study of 177Lu-satetraxetan-lilotomab in patients with relapsed/refractory indolent non-Hodgkin lymphoma (iNHL) has been published ahead of its presentation in a poster at the American Society of Hematology Annual Meeting & Exposition being held Dec. 1-4 in San Diego.

Read More

New! Disparities in Insurance Affect Survival Status in Follicular Lymphoma Patients

 Every year, about 14,000 people in the U.S. are diagnosed with follicular lymphoma (FL), the second most common type of non-Hodgkin lymphoma.

Read More

New! Evaluating 5F9 in Combination With Rituximab for Patients With Relapsed/Refractory NHL

 Proof-of-concept data from the phase 1b portion of a phase 1b/2 clinical trial evaluating 5F9 in combination with rituximab in patients with relapsed/refractory non-Hodgkin lymphoma (r/r NHL) was recently published in the New England Journal of Medicine (NEJM).

Read More

Free Downloads
The Bethesda Handbook of Clinical Hematology
  • Chronic Lymphocytic Leukemia Inhye E. Ahn, Clare Sun, and Adrian Wiestner
  • Non- Hodgkin Lymphomas              Richard F. Little

Download Now

Loading